Cutaneous adverse drug reaction type erythema multiforme major induced by eslicarbazepine

por Massot, Andreu, Gimenez-Arnau, Ana
Publicado 2014

Contact Urticaria Syndrome: a Comprehensive Review

por Giménez-Arnau, Ana M., Pesqué, David, Maibach, Howard I.
Publicado 2022

Omalizumab Updosing in Chronic Spontaneous Urticaria: an Overview of Real-World Evidence

por Metz, Martin, Vadasz, Zahava, Kocatürk, Emek, Giménez-Arnau, Ana M.
Publicado 2020

MI (2-methyl-4-isothiazolin-3-one) contained in detergents is not detectable in machine washed textiles

por Hofmann, Maja A., Giménez-Arnau, Ana, Aberer, Werner, Bindslev-Jensen, Carsten, Zuberbier, Torsten
Publicado 2018

Chronic urticaria in a health maintenance organization of Buenos Aires, Argentina - new data that increase global knowledge of this disease

por Parisi, Claudio Alberto, Ritchie, Carla, Petriz, Natalia, Torres, Christian Morelo, Gimenez-Arnau, Ana
Publicado 2018

Basophil Activation Test identifies the patients with Chronic Spontaneous Urticaria suffering the most active disease

por Curto‐Barredo, Laia, Yelamos, Jose, Gimeno, Ramon, Mojal, Sergi, Pujol, Ramon M., Giménez‐Arnau, Ana
Publicado 2016

Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results

por Maurer, Marcus, Giménez-Arnau, Ana, Ensina, Luis Felipe, Chu, Chia-Yu, Jaumont, Xavier, Tassinari, Paolo
Publicado 2020

Patch Testing with Propolis of Different Geographical Origins in a Baseline Series

por NYMAN, Gunnar S. A., GIMÉNEZ-ARNAU, Ana Maria, GRIGAITIENĖ, Jūratė, MALINAUSKIENE, Laura, PAULSEN, Evy, HAGVALL, Lina
Publicado 2021

Omalizumab for Patients with Chronic Spontaneous Urticaria: A Narrative Review of Current Status

por Casale, Thomas B., Gimenez-Arnau, Ana Maria, Bernstein, Jonathan A., Holden, Michael, Zuberbier, Torsten, Maurer, Marcus
Publicado 2023

The Expression of IL-17, in Chronic Spontaneous Urticaria Is Linked to Semaphorin5A

por Lobna, Matanis, Nasren, Eiza, Adi, Sabag, Jacob, Bejar, Maria, Gimenez-Arnau Ana, Marcus, Maurer, Zahava, Vadasz
Publicado 2021

IgE and high‐affinity IgE receptor in chronic inducible urticaria, pathogenic, and management relevance

por Giménez‐Arnau, Ana M., Ribas‐Llauradó, Clara, Mohammad‐Porras, Nasser, Deza, Gustavo, Pujol, Ramón M., Gimeno, Ramón
Publicado 2022

Remibrutinib inhibits hives effector cells stimulated by serum from chronic urticaria patients independently of FcεR1 expression level and omalizumab clinical response

por Gimeno, Ramón, Ribas‐Llauradó, Clara, Pesque, David, Andrades, Evelyn, Cenni, Bruno, Ambros, Barbara, Pujol, Ramon, Giménez‐Arnau, Ana M.
Publicado 2023

What lessons can we learn? Clinical and epidemiological retrospective analysis of 267 patients with urticaria in a Brazilian tertiary center()()

por Criado, Roberta Fachini Jardim, Criado, Paulo Ricardo, Baldavira, Nathalia, Cardial, Debora, Gimenez-Arnau, Ana Maria, Machado Filho, Carlos D’Apparecida
Publicado 2021

In silico Identification of Immune Cell-Types and Pathways Involved in Chronic Spontaneous Urticaria

por Prosty, Connor, Gabrielli, Sofianne, Ben-Shoshan, Moshe, Le, Michelle, Giménez-Arnau, Ana M., Litvinov, Ivan V., Lefrançois, Philippe, Netchiporouk, Elena
Publicado 2022

Why a Complete Response Is the Treatment Aim in Chronic Spontaneous Urticaria

por Bernstein, Jonathan A., Giménez-Arnau, Ana, Maurer, Marcus, Staubach, Petra, Barbier, Nathalie, Hua, Eva, Severin, Thomas, Laires, Pedro A., Balp, Maria-Magdalena
Publicado 2023

Improvement of sleep in patients with chronic idiopathic/spontaneous urticaria treated with omalizumab: results of three randomized, double-blind, placebo-controlled studies

por Gimenéz-Arnau, Ana M., Spector, Sheldon, Antonova, Evgeniya, Trzaskoma, Benjamin, Rosén, Karin, Omachi, Theodore A., Stull, Donald, Balp, Maria-Magdalena, Murphy, Thomas
Publicado 2016

Ligelizumab improves sleep interference and disease burden in patients with chronic spontaneous urticaria

por Giménez‐Arnau, Ana, Maurer, Marcus, Bernstein, Jonathan, Staubach, Petra, Barbier, Nathalie, Hua, Eva, Severin, Thomas, Joubert, Yolandi, Janocha, Reinhold, Balp, Maria‐Magdalena
Publicado 2022

SARS-CoV-2 Transmission from Presymptomatic Meeting Attendee, Germany

por Hijnen, DirkJan, Marzano, Angelo Valerio, Eyerich, Kilian, GeurtsvanKessel, Corine, Giménez-Arnau, Ana Maria, Joly, Pascal, Vestergaard, Christian, Sticherling, Michael, Schmidt, Enno
Publicado 2020

Study of Excipients in Delayed Skin Reactions to mRNA Vaccines: Positive Delayed Intradermal Reactions to Polyethylene Glycol Provide New Insights for COVID-19 Arm

por Pesqué, David, Pujol, Ramon Maria, Marcantonio, Orianna, Vidal-Navarro, Ainhoa, Ramada, José María, Arderiu-Formentí, Alba, Albalat-Torres, Agustí, Serra, Consol, Giménez-Arnau, Ana María
Publicado 2022

CRUSE – What the first 100 days have taught us

por Neisinger, Sophia, Pinto, Bernardo Sousa, Ramanauskaite, Aiste, Bousquet, Jean, Weller, Karsten, Metz, Martin, Magerl, Markus, Kocatürk, Emek, Ojeda, Ivan Cherrez, Gimenez-Arnau, Ana M, Maurer, Marcus
Publicado 2023